The sold production of diagnostic reagents and other pharmaceutical preparations in Germany showed varying trends from 2013 to 2023. The market experienced fluctuations, with notable increases in 2015, 2019, and 2021, evidenced by year-on-year adjustments of 9.42%, 9.38%, and 7.74%, respectively. The market faced downturns in 2014 and 2022, seeing declines of 6.84% and 8.98%. In 2023, the value of sold production rose by 2.19% to 1.7182 billion Euros.
Looking ahead from 2024 to 2028, a steady growth rate is forecasted, with expected year-on-year increases peaking at 1.57% by 2028, amounting to 1.8966 billion Euros. The projected 5-year CAGR is 1.57%, indicating a moderation in growth rate compared to previous years.
Future trends to watch for:
- Technological advancements in diagnostic reagents.
- Increased demand for personalized medicine.
- Impact of regulatory changes and healthcare policies.
- Shifts in global supply chain dynamics post-pandemic.
- Sustainability initiatives and their impact on production methodologies.
